Stay updated on ENABLE Study: Lanadelumab in HAE Clinical Trial
Sign up to get notified when there's something new on the ENABLE Study: Lanadelumab in HAE Clinical Trial page.

Latest updates to the ENABLE Study: Lanadelumab in HAE Clinical Trial page
- Check7 days agoChange DetectedThe study record history shows a new revision entry 'Revision: v3.6.3' added and the previous 'Revision: v3.6.2' removed, indicating a minor update to the history log display.SummaryDifference0.1%

- Check14 days agoChange DetectedA new record history entry for Revision: v3.6.2 has been added and the previous Revision: v3.6.0 entry has been removed. This update updates the version history display on the study record page to reflect the latest platform revision.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedA new revision (v3.6.0) was added to the study record. The study is now listed as no longer looking for participants, replacing the previous revision (v3.5.5).SummaryDifference0.4%

- Check36 days agoChange DetectedThe record history gains a new revision entry labeled v3.5.5, replacing the previous v3.5.4. This signals a software update to the history display rather than a change to the study data.SummaryDifference0.1%

- Check57 days agoChange DetectedA new site revision (v3.5.4) is added to the record history, replacing the previous revision (v3.5.3); this reflects a minor UI/backend update rather than changes to the trial information.SummaryDifference0.1%

- Check71 days agoChange DetectedA new Revision entry v3.5.3 has been added to the Record History, replacing the previous v3.5.2. This update reflects a change to the page's version history rather than to the study data or descriptions.SummaryDifference0.1%

Stay in the know with updates to ENABLE Study: Lanadelumab in HAE Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ENABLE Study: Lanadelumab in HAE Clinical Trial page.